ECRG4 and breast carcinoma: Although C2orf40 is highly expressed in various normal tissues, its expression is down-regulated in diverse types of cancer, including esophageal cancer [13], breast cancer [14], anaplastic thyroid carcinoma [15], and liver cancer [16], which may be partially due to the DNA hypermethylation at the promoter region [17, 18].